Although the way pulmonologists both treat and define PFF has evolved, the clinician’s role in identifying when pulmonary fibrosis becomes progressive is still a critical aspect of care.
Advancements in Interstitial Lung Disease (Podcast)
In a featured episode of Cleveland Clinic’s Respiratory Exchange podcast, Daniel Culver, DO, discusses the evolution in classification, diagnosis, treatment and management of interstitial lung disease.
Antisynthetase Syndrome and Mechanic’s Hands
Systemic treatment is often warranted as mechanic’s hands may be the most visible but not the only manifestation of antisynthetase syndrome.
Case Report: Common Variable Immunodeficiency and Lung Disease
A patient with common variable immunodeficiency, lung nodules and lymphadenopathy with potential for lymphoma requires a multidisciplinary approach.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Treprostinil: First Drug Approved for Patients with Pulmonary Hypertension and Interstitial Lung Disease
Compared with placebo, inhaled treprostinil was associated with lower risk of clinical worsening and fewer exacerbations of underlying lung disease during a 16-week treatment period.
Does Accurate Diagnosis Still Matter for Interstitial Lung Disease?
A multidisciplinary approach can uncover unsuspected diagnoses of interstitial lung disease. Many times this precision makes a difference in management strategy and patient outcomes.
COVID-19 and Underlying Chronic Lung Disease: What Is Known About Risk and Managing Care
Patients with COVID-19 who have underlying chronic lung disease are at increased risk for developing severe illness. Pulmonologist Brian Southern, MD, recently authored a review article in Cleveland Clinic Journal of Medicine’s COVID-19 Curbside Consults series. In this article, he takes a closer look at what is known about ILD and sarcoidosis in the context of the pandemic and offers insights for managing care.
Socioeconomic Disparities and Outcomes in Patients With Sarcoidosis
Mild symptoms and a quick recovery are common in most cases of sarcoidosis, but a minority of patients have significant morbidity and impaired quality of life because of multiorgan involvement. A new Cleveland Clinic study examines association between income and sarcoidosis outcomes, after controlling for socioeconomic and disease-related factors.
A Paradigm Shift in the Treatment of Scleroderma-Associated Interstitial Lung Disease
Kristin Highland, MD, discusses new potential pathways to treat scleroderma-associated interstitial lung disease.
Trial Results Offer New Hope for Scleroderma Patients
Results from a just-published landmark trial could lead to the first-ever approved drug for the treatment of systemic scleroderma-associated interstitial lung disease.